Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

Gampenrieder SP, Rinnerthaler G, Hackl H, Pulverer W, Weinhaeusel A, Ilic S, Hufnagl C, Hauser-Kronberger C, Egle A, Risch A, Greil R.

Theranostics. 2018 Mar 11;8(8):2278-2288. doi: 10.7150/thno.23544. eCollection 2018.

2.

Multiplexed and Sensitive DNA Methylation Testing Using Methylation-Sensitive Restriction Enzymes "MSRE-qPCR".

Beikircher G, Pulverer W, Hofner M, Noehammer C, Weinhaeusel A.

Methods Mol Biol. 2018;1708:407-424. doi: 10.1007/978-1-4939-7481-8_21.

PMID:
29224156
3.

Inhibitors of DNA methylation support TGF-β1-induced IL11 expression in gingival fibroblasts.

Sufaru IG, Beikircher G, Weinhaeusel A, Gruber R.

J Periodontal Implant Sci. 2017 Apr;47(2):66-76. doi: 10.5051/jpis.2017.47.2.66. Epub 2017 Apr 29.

4.

Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling.

Hassler MR, Pulverer W, Lakshminarasimhan R, Redl E, Hacker J, Garland GD, Merkel O, Schiefer AI, Simonitsch-Klupp I, Kenner L, Weisenberger DJ, Weinhaeusel A, Turner SD, Egger G.

Cell Rep. 2016 Oct 4;17(2):596-608. doi: 10.1016/j.celrep.2016.09.018.

5.

Analysis and Visualization Tool for Targeted Amplicon Bisulfite Sequencing on Ion Torrent Sequencers.

Pabinger S, Ernst K, Pulverer W, Kallmeyer R, Valdes AM, Metrustry S, Katic D, Nuzzo A, Kriegner A, Vierlinger K, Weinhaeusel A.

PLoS One. 2016 Jul 28;11(7):e0160227. doi: 10.1371/journal.pone.0160227. eCollection 2016.

6.

MethylMeter(®): bisulfite-free quantitative and sensitive DNA methylation profiling and mutation detection in FFPE samples.

McCarthy D, Pulverer W, Weinhaeusel A, Diago OR, Hogan DJ, Ostertag D, Hanna MM.

Epigenomics. 2016 Jun;8(6):747-65. doi: 10.2217/epi-2016-0004. Epub 2016 Jun 23.

7.

The pre-analytical processing of blood samples for detecting biomarkers on protein microarrays.

Rosskopf S, Gyurján I, Soldo R, Luna-Coronell JA, Vierlinger K, Singer CF, Rappaport C, Pecha N, Weinhaeusel A.

J Immunol Methods. 2015 Mar;418:39-51. doi: 10.1016/j.jim.2015.01.009. Epub 2015 Feb 9. Erratum in: J Immunol Methods. 2015 Apr;419:57. Soldo, Regina [Added].

PMID:
25675867
8.

Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies.

Brezina S, Soldo R, Kreuzhuber R, Hofer P, Gsur A, Weinhaeusel A.

Microarrays (Basel). 2015 Apr 2;4(2):162-87. doi: 10.3390/microarrays4020162.

9.

Strategies for validation and testing of DNA methylation biomarkers.

Noehammer C, Pulverer W, Hassler MR, Hofner M, Wielscher M, Vierlinger K, Liloglou T, McCarthy D, Jensen TJ, Nygren A, Gohlke H, Trooskens G, Braspenning M, Van Criekinge W, Egger G, Weinhaeusel A.

Epigenomics. 2014;6(6):603-22. doi: 10.2217/epi.14.43. Review.

PMID:
25531255
10.

Epigenetic differences in human cartilage between mild and severe OA.

Moazedi-Fuerst FC, Hofner M, Gruber G, Weinhaeusel A, Stradner MH, Angerer H, Peischler D, Lohberger B, Glehr M, Leithner A, Sonntagbauer M, Graninger WB.

J Orthop Res. 2014 Dec;32(12):1636-45. doi: 10.1002/jor.22722. Epub 2014 Sep 12.

11.

A simple quantitative diagnostic alternative for MGMT DNA-methylation testing on RCL2 fixed paraffin embedded tumors using restriction coupled qPCR.

Pulverer W, Hofner M, Preusser M, Dirnberger E, Hainfellner JA, Weinhaeusel A.

Clin Neuropathol. 2014 Jan-Feb;33(1):50-60. doi: 10.5414/NP300633.

PMID:
23993306
12.

Chordoma characterization of significant changes of the DNA methylation pattern.

Rinner B, Weinhaeusel A, Lohberger B, Froehlich EV, Pulverer W, Fischer C, Meditz K, Scheipl S, Trajanoski S, Guelly C, Leithner A, Liegl B.

PLoS One. 2013;8(3):e56609. doi: 10.1371/journal.pone.0056609. Epub 2013 Mar 22.

13.

A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression.

van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, Weinhaeusel A, Bilban M, Berger W, Mikulits W.

Mol Cancer Ther. 2011 May;10(5):850-60. doi: 10.1158/1535-7163.MCT-10-0917. Epub 2011 Mar 1.

14.

RGG: a general GUI Framework for R scripts.

Visne I, Dilaveroglu E, Vierlinger K, Lauss M, Yildiz A, Weinhaeusel A, Noehammer C, Leisch F, Kriegner A.

BMC Bioinformatics. 2009 Mar 2;10:74. doi: 10.1186/1471-2105-10-74.

15.

The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.

Weinhaeusel A, Scheuba C, Lauss M, Kriegner A, Kaserer K, Vierlinger K, Haas OA, Niederle B.

Thyroid. 2008 Dec;18(12):1269-76. doi: 10.1089/thy.2008.0139.

PMID:
18976163
16.

PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib.

Weinhaeusel A, Thiele S, Hofner M, Hiort O, Noehammer C.

Clin Chem. 2008 Sep;54(9):1537-45. doi: 10.1373/clinchem.2008.104216. Epub 2008 Jul 10.

17.

MethCancerDB--aberrant DNA methylation in human cancer.

Lauss M, Visne I, Weinhaeusel A, Vierlinger K, Noehammer C, Kriegner A.

Br J Cancer. 2008 Feb 26;98(4):816-7. doi: 10.1038/sj.bjc.6604219. Epub 2008 Feb 5.

18.

Comparison of RNA amplification techniques meeting the demands for the expression profiling of clinical cancer samples.

Lauss M, Vierlinger K, Weinhaeusel A, Szameit S, Kaserer K, Noehammer C.

Virchows Arch. 2007 Dec;451(6):1019-29. Epub 2007 Oct 31.

PMID:
17972098
19.

Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Leithner K, Leithner A, Clar H, Weinhaeusel A, Radl R, Krippl P, Rehak P, Windhager R, Haas OA, Olschewski H.

Orphanet J Rare Dis. 2006 Nov 7;1:44.

20.

Evidence of a polyclonal nature of myositis ossificans.

Leithner A, Weinhaeusel A, Zeitlhofer P, Koch H, Radl R, Windhager R, Beham A, Haas OA.

Virchows Arch. 2005 Apr;446(4):438-41. Epub 2005 Mar 11.

PMID:
15761759
21.
22.

Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas.

Leithner A, Weinhaeusel A, Windhager R, Schlegl R, Waldner P, Lang S, Dominkus M, Zoubek A, Popper HH, Haas OA.

Cancer Biol Ther. 2002 Jul-Aug;1(4):375-9.

PMID:
12432250
23.

A novel mutation E179K of the MEN1 gene predisposes for multiple endocrine neoplasia-type 1 (MEN1).

Weinhaeusel A, Vierhapper H, Schlegl R, Wagner T, Muhr D, Scheuba C, Niederle B, Haas OA.

Hum Mutat. 2000 Dec;16(6):533. No abstract available.

PMID:
11102994

Supplemental Content

Loading ...
Support Center